Cidara Therapeutics
CDTX
CDTX
52 hedge funds and large institutions have $29.7M invested in Cidara Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 54 → 52 (-2)
14% less capital invested
Capital invested by funds: $34.4M → $29.7M (-$4.75M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
52
Holding in Top 10
1
Calls
$80K
Puts
$3K
Top Buyers
| 1 | +$362K | |
| 2 | +$339K | |
| 3 | +$331K | |
| 4 |
BlackRock
New York
|
+$249K |
| 5 |
Morgan Stanley
New York
|
+$212K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$868K | |
| 3 | -$524K | |
| 4 |
Jane Street
New York
|
-$389K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$90.6K |